Answer
It is unknown whether Dianeal PD4 metabolites enter human milk, and infant risk cannot be excluded; whether to stop breastfeeding or discontinue or abstain from therapy must be decided by weighing breastfeeding benefits for the child against treatment benefits for the woman.
Sources for this answer
- Dianeal PD4 Glucose 1.36% w/v 13.6 mg/mlVantive Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked